Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.
Tickets still are available for anyone who wishes to celebrate the Kentucky Derby and support the Brown-Pusey House.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results